x

NEW UPDATE: Completed trials may now upload and register supplementary documents (e.g. null results reports, populated pre-analysis plans, or post-trial results reports) in the Post Trial section under Reports, Papers, & Other Materials.
VC in China
Last registered on June 23, 2020

Pre-Trial

Trial Information
General Information
Title
VC in China
RCT ID
AEARCTR-0006039
Initial registration date
June 22, 2020
Last updated
June 23, 2020 11:10 AM EDT
Location(s)

This section is unavailable to the public. Use the button below to request access to this information.

Request Information
Primary Investigator
Affiliation
Other Primary Investigator(s)
Additional Trial Information
Status
On going
Start date
2019-04-01
End date
2021-04-01
Secondary IDs
Abstract
This study aims to estimate the preferences of venture capital investors in China.
External Link(s)
Registration Citation
Citation
Colonnelli, Emanuele. 2020. "VC in China." AEA RCT Registry. June 23. https://doi.org/10.1257/rct.6039-1.0.
Experimental Details
Interventions
Intervention(s)
This study aims to estimate the preferences of venture capital investors in China using an incentivized choice experiment with real stakes.
Intervention Start Date
2019-04-01
Intervention End Date
2020-06-30
Primary Outcomes
Primary Outcomes (end points)
Choice of an investment partner with specific characteristics.
Primary Outcomes (explanation)
See pdf attachment for additional details.
Secondary Outcomes
Secondary Outcomes (end points)
Secondary Outcomes (explanation)
Experimental Design
Experimental Design
This study aims to estimate the preferences of venture capital investors in China using an incentivized choice experiment with real stakes.
Experimental Design Details
Not available
Randomization Method
Randomization done in office by a computer.
Randomization Unit
Randomization is done to ensure that profiles are randomly created. See pdf attachment for additional details.
Was the treatment clustered?
No
Experiment Characteristics
Sample size: planned number of clusters
Approximately 800 fund managers and 300 investors.
Sample size: planned number of observations
Approximately 22,000 (800*20+300*20)
Sample size (or number of clusters) by treatment arms
See pdf attachment for additional details.
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB
INSTITUTIONAL REVIEW BOARDS (IRBs)
IRB Name
IRB Approval Date
IRB Approval Number
Analysis Plan

There are documents in this trial unavailable to the public. Use the button below to request access to this information.

Request Information